跳至主要内容
临床试验/NCT03710551
NCT03710551已完成不适用

Stool Composition and GI Tolerance in Infants Fed a Term Infant Formula With a New Fat Blend Plus L.Reuteri: a Randomized Controlled Trial

Société des Produits Nestlé (SPN)2 个研究点 分布在 1 个国家目标入组 140 人开始时间: 2018年9月26日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
140
试验地点
2
主要终点
Stool Consistency Score

研究概览

简要总结

The purpose of this study is to evaluate the stool composition and GI tolerance of an experimental formula with a new fat blend plus L. reuteri vs control formula.

详细描述

Double-blind, randomized, controlled clinical trial. The purpose of this study is to evaluate the stool composition and GI tolerance of 140 healthy, term infants fed with an infant formula with a new fat blend plus L. reuteri vs a standard infant formula. All enrolled infants will participate in the trial for approximately 71 days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Days 至 28 Days(Child)
性别
All
接受健康志愿者

入选标准

  • Written Informed Consent
  • Infants whose parents/LAR have reached the legal age of majority in the Philippines
  • Infants whose parent(s)/LAR are willing and able to comply with scheduled visits, and the requirements of the study protocol
  • Infants whose parent(s)/LAR are able to be contacted directly by telephone throughout the study
  • Healthy term, singleton infant at birth
  • Between 21 to 28 days post-natal age at enrollment visit
  • Weight-for-age ≥ 5th and ≤ 95th percentile according to World Health Organization growth tables/charts
  • Infants of parent(s)/LAR who have previously made the decision to formula feed their infant at the time of enrollment

排除标准

  • Infants with conditions requiring infant feedings other than those specified in the protocol
  • Infants receiving complementary foods or liquids
  • Infants who have a medical condition or history that could increase the risk associated with study participation or interfere with the interpretation of study results
  • Infants who are presently receiving or have received medications that could interfere with the interpretation of the study results

结局指标

主要结局

Stool Consistency Score

时间窗: Study Day 57, corresponding to infant age of 78-85 days

3-day Gastrointestinal (GI) Symptom and Behavior Diary, a parent-reported symptom diary to record stool consistency and stool frequency over the 3 consecutive days. A validated 5-point pictorial representation of the consistency of the stool for infants ≤1 year (1=watery, 2=runny, 3=mushy soft, 4=formed, 5=hard) will be provided in the stool diary for parent(s)/LAR to visually assess the infants' stools. Stool consistency will be compared between formula groups The baseline stool consistency value will also be included in the model as a covariate. the percentage of stools in each category (watery, runny, mushy soft, formed, or hard) will be calculated by visit for each infant and then will be summarized using the appropriate descriptive statistics. Figures composed of a series of histograms will be produced for each 3-day stool diary period.

次要结局

  • Changes in Weight from baseline to 57 days(Study Day 57, corresponding to infant age of 78-85 days)
  • GI Tolerance(which corresponds to infant age of 21-28, 43-50, and 78-85 days.)
  • Changes in Length from baseline to 57 days(Study Day 57, corresponding to infant age of 78-85 days)
  • Changes in Head Circumference from baseline to 57 days(Study Day 57, corresponding to infant age of 78-85 days)

研究者

发起方
Société des Produits Nestlé (SPN)
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验